Rite Aid Reports Fiscal 2018 Third Quarter Results

Walgreens Boosts Alliance (WBA) PT Lowered to $73 at Pivotal Research Following 1Q

Pivotal Research lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $73.00 (from $81.00) while maintaining a Hold rating following the company's 1Q release. WBA reported better than expected 1Q18 earnings with adjusted EPS of $1.28 ($0.02 higher than estimates). However, heavier than expected share... More

Rite Aid (RAD) Will Close Up Today, Susquehanna's Stauff Predicts

Susquehanna's special situation analyst Joe Stauff said while Rite Aid (NYSE: RAD) is trading lower pre-open they expect the stock to be up on the day following Q3 results. He provided 4 primary take-aways:

Divestiture Closings Accelerating and Will Reduce RAD's Debt To ~$3B By April. Management seemed VERY confident in the divestiture closing process (as of 1/3/18, RAD closed 356 store closings receiving $714m in proceeds or 18.5% of the 1,932 stores to be sold) and repeatedly reiterated that they expect to complete the closing by end of April 2018 ("spring," "in fiscal 1Q"... More

Rite-Aid (RAD) PT Raised to $2.50 at Cowen Following Better Q3

Cowen analyst Charles Rhyee raised his price target on Rite-Aid (NYSE: RAD) to $2.50 (from $2.15) while maintaining a Outperform rating following better-than-expected Q3 results.

Rhyee commented, "Proforma F3Q18 results came in better than we expected with adj. EBITDA of $153M (ex-corp expenses... More

Rite Aid (RAD) Tops Q3 EPS by 2c, Revenue Comes in Light

Rite Aid (NYSE: RAD) reported Q3 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $5.4 billion versus the consensus estimate of $7.45 billion.

Same store sales from continuing operations for the quarter decreased 2.5 percent from the prior year,... More